SAUL RIVERA: Open Payments
NPI 1821508938 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,402 in 50 payments from 15 companies in 2025. Trend: 2023 $930 · 2024 $332 · 2025 $1,402
Food & beverage: $1,202Education: $200
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $335 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $151 |
| UROGEN PHARMA, INC. | 3 | $146 |
| PFIZER INC. | 6 | $127 |
| Merck Sharp & Dohme LLC | 1 | $123 |
| SEAGEN INC. | 1 | $100 |
| Novartis Pharmaceuticals Corporation | 3 | $83 |
| Boston Scientific Corporation | 3 | $74 |
| Astellas Pharma US Inc | 3 | $69 |
| Sumitomo Pharma America, Inc. | 2 | $56 |
Products named: ERLEADA, XTANDI, Nubeqa, PLUVICTO, GEMTESA, JELMYTO, Camcevi, Bulkamid.
Industry payments across AZ — which companies pay providers there.
